Carl Byrnes
Stock Analyst at Northland Capital Markets
(3.49)
# 853
Out of 5,173 analysts
27
Total ratings
50%
Success rate
34.9%
Average return
Main Sectors:
Stocks Rated by Carl Byrnes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RCEL AVITA Medical | Initiates: Outperform | $10 | $3.95 | +153.16% | 1 | Mar 5, 2026 | |
| BWAY BrainsWay | Maintains: Outperform | $9.5 → $12 | $13.71 | -16.12% | 5 | Nov 12, 2025 | |
| SNWV SANUWAVE Health | Initiates: Outperform | $55 | $20.52 | +168.03% | 1 | Sep 3, 2025 | |
| BLFS BioLife Solutions | Maintains: Outperform | $28 → $31 | $19.18 | +61.63% | 2 | Jan 8, 2025 | |
| TLSI TriSalus Life Sciences | Initiates: Outperform | $13 | $3.92 | +218.88% | 1 | Oct 25, 2024 | |
| MDAI Spectral AI | Initiates: Outperform | $6 | $1.72 | +248.84% | 1 | Aug 12, 2024 | |
| COCH Envoy Medical | Initiates: Outperform | n/a | $0.77 | - | 1 | Dec 21, 2023 | |
| AMRN Amarin Corporation | Maintains: Market Perform | $40 → $25 | $14.58 | +71.53% | 1 | Jul 19, 2023 | |
| CDIO Cardio Diagnostics Holdings | Initiates: Outperform | $240 | $2.25 | +10,566.67% | 1 | May 22, 2023 | |
| VTVT vTv Therapeutics | Maintains: Outperform | $60 → $80 | $37.87 | +111.25% | 4 | Aug 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $23 | $4.24 | +442.45% | 3 | Jul 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $30 → $24 | $2.62 | +816.03% | 4 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $2,000 | $2.65 | +75,371.70% | 1 | Oct 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $0.80 | - | 1 | Sep 27, 2017 |
AVITA Medical
Mar 5, 2026
Initiates: Outperform
Price Target: $10
Current: $3.95
Upside: +153.16%
BrainsWay
Nov 12, 2025
Maintains: Outperform
Price Target: $9.5 → $12
Current: $13.71
Upside: -16.12%
SANUWAVE Health
Sep 3, 2025
Initiates: Outperform
Price Target: $55
Current: $20.52
Upside: +168.03%
BioLife Solutions
Jan 8, 2025
Maintains: Outperform
Price Target: $28 → $31
Current: $19.18
Upside: +61.63%
TriSalus Life Sciences
Oct 25, 2024
Initiates: Outperform
Price Target: $13
Current: $3.92
Upside: +218.88%
Spectral AI
Aug 12, 2024
Initiates: Outperform
Price Target: $6
Current: $1.72
Upside: +248.84%
Envoy Medical
Dec 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $0.77
Upside: -
Amarin Corporation
Jul 19, 2023
Maintains: Market Perform
Price Target: $40 → $25
Current: $14.58
Upside: +71.53%
Cardio Diagnostics Holdings
May 22, 2023
Initiates: Outperform
Price Target: $240
Current: $2.25
Upside: +10,566.67%
vTv Therapeutics
Aug 17, 2022
Maintains: Outperform
Price Target: $60 → $80
Current: $37.87
Upside: +111.25%
Jul 26, 2021
Initiates: Outperform
Price Target: $23
Current: $4.24
Upside: +442.45%
May 5, 2021
Maintains: Market Perform
Price Target: $30 → $24
Current: $2.62
Upside: +816.03%
Oct 22, 2018
Initiates: Outperform
Price Target: $2,000
Current: $2.65
Upside: +75,371.70%
Sep 27, 2017
Initiates: Outperform
Price Target: n/a
Current: $0.80
Upside: -